Dennis Reilly is Chief Financial Officer of AGILE THERAPEUTICS INC. Currently has a direct ownership of 285,130 shares of AGRX, which is worth approximately $0. The most recent transaction as insider was on Oct 13, 2021, when has been sold 58,824 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 285K
0% 3M change
0% 12M change
Total Value Held $0

Dennis Reilly Transaction History

Date Transaction Value Shares Traded Shares Held Form
Oct 13 2021
BUY
Open market or private purchase
-
58,824 Added 17.1%
285,130 Common Stock
Jul 27 2021
BUY
Open market or private purchase
$54,000 $1.08 p/Share
50,000 Added 18.1%
226,306 Common Stock
May 11 2021
BUY
Open market or private purchase
$27,000 $1.35 p/Share
20,000 Added 10.19%
176,306 Common Stock
Mar 23 2021
BUY
Open market or private purchase
$102,500 $2.05 p/Share
50,000 Added 24.24%
156,306 Common Stock
DR

Dennis Reilly

Chief Financial Officer
Princeton, NJ

Track Institutional and Insider Activities on AGRX

Follow AGILE THERAPEUTICS INC and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells AGRX shares.

Notify only if

Insider Trading

Get notified when an Agile Therapeutics Inc insider buys or sells AGRX shares.

Notify only if

News

Receive news related to AGILE THERAPEUTICS INC

Track Activities on AGRX